Advanced HIV: Outcomes for Rapid ART
Condition: HIV-1-infection Intervention: Drug: Bictegravir/emtricitabine/tenofovir alafenamide Sponsors: Valley AIDS Council; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2022 Category: Research Source Type: clinical trials
Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis
Conditions: HIV Infection Primary; Hepatitis, Viral, Human; Sexually Transmitted Infections, Excluding HIV and Hepatitis Intervention: Drug: Tenofovir Disoproxil Fumarate 300 MG Oral Tablet Sponsors: Hospitales Universitarios Virgen del Rocío; Instituto de Biomedicina de Sevilla Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2022 Category: Research Source Type: clinical trials